Treatment of depression and anxiety in Parkinson’s Disease
| dc.contributor.author | Troeung, Lakkhina | |
| dc.contributor.supervisor | Dr Sarah Egan | |
| dc.contributor.supervisor | Dr Andrea Loftus | |
| dc.contributor.supervisor | Dr Natalie Gasson | |
| dc.date.accessioned | 2017-01-30T09:57:52Z | |
| dc.date.available | 2017-01-30T09:57:52Z | |
| dc.date.created | 2013-11-22T05:41:55Z | |
| dc.date.issued | 2013 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/1044 | |
| dc.description.abstract |
This thesis examined the treatment of depression and anxiety in Parkinson’s disease (PD) and comprised four studies. Study 1 was a meta-analysis of treatments for depression and anxiety in PD. Study 2 examined the validity of the DASS-21 as an assessment tool in PD. Study 3 was a randomised controlled trial of group CBT for depression and anxiety in PD. Study 4 was a cross-sectional cohort study examining mental health service utilisation and barriers to treatment. | |
| dc.language | en | |
| dc.publisher | Curtin University | |
| dc.title | Treatment of depression and anxiety in Parkinson’s Disease | |
| dc.type | Thesis | |
| dcterms.educationLevel | PhD | |
| curtin.department | School of Psychology and Speech Pathology, Faculty of Health Sciences | |
| curtin.accessStatus | Open access |